CALIPER SETTLES OUTSTANDING LITIGATION WITH SHIMADZU

Printer-friendly versionPDF version

March 15, 2010

HOPKINTON, Mass., March 15, 2010 -- Caliper Life Sciences, Inc. (NASDAQ: CALP), a leading provider of tools and services for drug discovery and life sciences research, today announces that it has entered into a settlement agreement with Shimadzu Corporation and its wholly owned subsidiary Shimadzu Scientific Instruments, Inc., resolving a lawsuit filed by Caliper in the United States District Court for the Eastern District of Texas that claimed that Shimadzu’s MultiNA microchip-based electrophoresis system infringed several U.S. patents relating to Caliper’s microfluidic LabChip® technology.  Shimadzu denies infringement, but has discontinued sales of the MultiNA system in the United States.  The terms of the settlement were not disclosed.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper’s portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visitwww.caliperLS.com.

Caliper and LabChip are registered trademarks of Caliper Life Sciences, Inc.

Contact:      
Peter McAree     
SVP and Chief Financial Officer   
Caliper Life Sciences    
508.497.2215     

Media Contact:
Ben Navon/Kristin Villiotte
Schwartz Communications
781.684.0770

caliper@schwartz-pr.com 

###

News Source : CALIPER SETTLES OUTSTANDING LITIGATION WITH SHIMADZU